HEXAGON

Hexagon Nutrition Limited

Science-led human nutrition solutions across premixes, therapeutic and clinical nutrition

Fast Moving Consumer Goods›Fast Moving Consumer Goods›Food Products›Other Food Products

hexagonnutrition.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹73.15
Market cap
899 Cr
Stock P/E
21.3 · FY26
P/B
3.45
ROE (FY26)
16.3%
ROCE (FY26)
20.9%
Operating margin (FY26)
11.2%
Debt / equity (FY26)
0.13
OCF / EBITDA (FY26)
11.8%
OCF / EBITDA (3Y)
57.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Hexagon Nutrition makes nutrition products in three lines, micronutrient premixes, branded nutrition products and therapeutic foods, for customers in India and export markets.

Company snapshot

5thBy market cap

Ranked among 8 companies in Other Food Products.

What we see

Positives
  • ✓Revenue grew 18% in the latest year — strong top-line momentum.
3 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2026Jun 2026
Sales115 Cr104 Cr
Operating expenses (approx.)100 Cr93 Cr
EBITDA15 Cr12 Cr
OPM %13.1%11.3%
Other income4 Cr2 Cr
Interest1 Cr0.98 Cr
Depreciation3 Cr2 Cr
Profit before tax15 Cr11 Cr
Tax %29.3%23.8%
Net profit11 Cr8 Cr
EPS (₹)₹0.99₹0.67

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales279 Cr298 Cr325 Cr383 CrSign in free for the trailing twelve months
Operating expenses (approx.)256 Cr273 Cr284 Cr330 CrSign in free for the trailing twelve months
EBITDA22 Cr25 Cr41 Cr53 CrSign in free for the trailing twelve months
OPM %8.0%8.2%12.6%13.7%Sign in free for the trailing twelve months
Other income3 Cr7 Cr6 Cr12 CrSign in free for the trailing twelve months
Interest3 Cr4 Cr4 Cr4 CrSign in free for the trailing twelve months
Depreciation8 Cr8 Cr9 Cr10 CrSign in free for the trailing twelve months
Profit before tax9 Cr20 Cr34 Cr51 CrSign in free for the trailing twelve months
Tax %38.2%37.4%27.7%25.9%Sign in free for the trailing twelve months
Net profit6 Cr12 Cr24 Cr38 CrSign in free for the trailing twelve months
EPS (₹)₹0.51₹1.10₹1.75₹3.43Sign in free for the trailing twelve months
Dividend payout %———0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2023Mar 2024Mar 2025Mar 2026
Equity capital11 Cr11 Cr11 Cr11 Cr
Reserves152 Cr165 Cr183 Cr222 Cr
Borrowings52 Cr37 Cr27 Cr30 Cr
Other liabilities74 Cr38 Cr41 Cr55 Cr
Total liabilities289 Cr251 Cr261 Cr318 Cr
Fixed assets (net)54 Cr63 Cr62 Cr61 Cr
CWIP4 Cr2 Cr3 Cr3 Cr
Investments30 Cr19 Cr34 Cr37 Cr
Inventories88 Cr79 Cr61 Cr84 Cr
Trade receivables74 Cr49 Cr60 Cr82 Cr
Cash & bank11 Cr19 Cr15 Cr16 Cr
Other assets27 Cr19 Cr26 Cr36 Cr
Total assets289 Cr251 Cr261 Cr318 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-0.0010 Cr23 Cr38 Cr6 Cr
Cash from investing-19 Cr4 Cr-23 Cr-6 Cr
Cash from financing7 Cr-19 Cr-19 Cr-0.42 Cr
Net cash flow-12 Cr8 Cr-4 Cr0.55 Cr
Free cash flow (OCF − Capex)-6 Cr8 Cr28 Cr-1 Cr

Ratios

MetricMar 2023Mar 2024Mar 2025Mar 2026
ROCE %5.9%11.1%17.1%20.9%
ROE %3.6%6.9%12.6%16.3%
Debtor days97596778
Inventory days176210141151
Days payable91524352
Cash conversion cycle182218165177
OCF / EBITDA %-0.0%95.4%92.5%11.8%
OCF / EBITDA % (3 years)——69.7%57.1%
Debt / equity0.320.210.140.13
Current ratio1.932.983.493.38
Net debt / EBITDA1.810.720.280.28